This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Musk files reply for dismissal of OpenAI's US counterclaims over for-profit status

( June 11, 2025, 15:57 GMT | Official Statement) -- MLex Summary: Lawyers for Elon Musk filed a reply in support of a motion to dismiss counterclaims by OpenAI alleging unfair competition and tortious interference, based on Musk's letters to regulators such as the attorneys general of California and Delaware, saying OpenAI is trying to “have its cake and it eat too.” “OpenAI’s counterclaims, like so much of its conduct surrounding this litigation, amount to a crisis-comms campaign designed to distract from the one indisputably true and inescapable fact: OpenAI was founded as a charity for the public’s benefit, but now it desires to enrich insiders like Sam Altman and his investors instead. And the less the charity is compensated for its assets, the greater their profits,” they argued. See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections